Europe — EMA
Paracetamol Combino Pharm
GNH USA supplies Paracetamol Combino Pharm (Paracetamol), a analgesic/antipyretic for pain and fever in hospitals and clinics.
Request sourcing
What is Paracetamol?
Paracetamol, the active ingredient in Paracetamol Combino Pharm, is an analgesic presented as an intravenous solution for intravenous use. It provides relief from pain and reduces fever in adult and pediatric patients when administered under medical supervision. The product conforms to European Union quality standards and is indicated for short‑term management of moderate pain and febrile states.
GNH USA supplies Paracetamol Combino Pharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres and oncology centres worldwide, ensuring reliable sourcing and regulatory compliance for healthcare providers.
What is Paracetamol used for?
Paracetamol Combino Pharm is used to manage pain and fever by acting on the central prostaglandin pathway.
- Pain: provides analgesic relief for mild to moderate pain. - Fever: lowers elevated body temperature in febrile states. - Post‑operative pain: offers short‑term analgesia following surgical procedures. - Headache: alleviates tension‑type and mild migraine headaches. - Dental pain: reduces discomfort associated with dental procedures. - Musculoskeletal pain: eases soreness from strains or minor injuries.
What are the side effects of Paracetamol?
Paracetamol Combino Pharm may be associated with a range of adverse reactions, most of which are mild and reversible.
Common Side Effects: - Nausea: mild nausea may occur after infusion. - Injection site pain: discomfort at the intravenous site. - Elevated liver enzymes: transient increase in hepatic transaminases. - Vomiting: occasional episodes of vomiting. - Transient hypotension: brief drop in blood pressure during infusion.
Serious or Rare Side Effects: - Severe hepatotoxicity: risk of liver injury, especially with overdose. - Anaphylaxis: rare severe allergic reaction requiring immediate treatment. - Stevens‑Johnson syndrome: rare severe skin reaction.
What precautions apply to Paracetamol?
When using Paracetamol Combino Pharm, several precautions should be observed to ensure safe administration.
- Liver function assessment: evaluate hepatic enzymes before initiating therapy. - Dose adjustment in hepatic impairment: reduce or avoid use in severe liver disease. - Caution with alcohol: limit alcohol consumption to reduce hepatotoxic risk. - Avoid concurrent hepatotoxic drugs: monitor when used with other liver‑affecting medications. - Monitor for allergic reactions: discontinue if signs of hypersensitivity appear. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Paracetamol interact with?
Paracetamol Combino Pharm can interact with other medicines, influencing its efficacy or safety.
Major Interactions (Avoid): - Hepatotoxic agents: concurrent use with other liver‑damaging drugs may increase risk of liver injury. - Warfarin: paracetamol may enhance anticoagulant effect, raising INR levels. - Alcohol: combined intake can potentiate hepatotoxicity. - High-dose acetylsalicylic acid: combined use may increase risk of renal impairment.
Moderate Interactions (Monitor Closely): - Enzyme inducers (e.g., carbamazepine, phenytoin): may reduce paracetamol plasma concentrations. - CYP450 inhibitors (e.g., fluconazole): may increase paracetamol levels modestly. - Methotrexate: concurrent use may increase hepatotoxic risk.



